Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Piro

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Prion|June 8, 2011
Photodegradation illuminates the role of polyanions in prion infectivityJustin R Piro, Surachai Supattapone
Plos Pathogens|February 10, 2011
In situ photodegradation of incorporated polyanion does not alter prion infectivityJustin R Piro, Brent T Harris, Surachai Supattapone
CNS & Neurological Disorders Drug Targets|August 26, 2009
Complex polyamines: unique prion disaggregating compoundsSurachai Supattapone, Justin R Piro, Judy R Rees
Preparative Biochemistry & Biotechnology|January 14, 2012
Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion proteinDaniel J Walsh, Geoffrey P Noble, Justin R Piro, et al.
Biochemistry|July 23, 2011
Seeding specificity and ultrastructural characteristics of infectious recombinant prionsJustin R Piro, Fei Wang, Daniel J Walsh, et al.
Journal of Virology|March 20, 2009
Prion protein glycosylation is not required for strain-specific neurotropismJustin R Piro, Brent T Harris, Koren Nishina, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2012
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acidsNathan R Deleault, Justin R Piro, Daniel J Walsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prionsNathan R Deleault, Daniel J Walsh, Justin R Piro, et al.
Frontiers in Pharmacology|September 12, 2019
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and DevelopmentKnut Biber, Anindya Bhattacharya, Brian M Campbell, et al.
Cell Reports|July 21, 2012
A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's diseaseJustin R Piro, Daniel I Benjamin, James M Duerr, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Prion|June 8, 2011
Photodegradation illuminates the role of polyanions in prion infectivityJustin R Piro, Surachai Supattapone
Plos Pathogens|February 10, 2011
In situ photodegradation of incorporated polyanion does not alter prion infectivityJustin R Piro, Brent T Harris, Surachai Supattapone
CNS & Neurological Disorders Drug Targets|August 26, 2009
Complex polyamines: unique prion disaggregating compoundsSurachai Supattapone, Justin R Piro, Judy R Rees
Preparative Biochemistry & Biotechnology|January 14, 2012
Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion proteinDaniel J Walsh, Geoffrey P Noble, Justin R Piro, et al.
Biochemistry|July 23, 2011
Seeding specificity and ultrastructural characteristics of infectious recombinant prionsJustin R Piro, Fei Wang, Daniel J Walsh, et al.
Journal of Virology|March 20, 2009
Prion protein glycosylation is not required for strain-specific neurotropismJustin R Piro, Brent T Harris, Koren Nishina, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2012
Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acidsNathan R Deleault, Justin R Piro, Daniel J Walsh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2012
Cofactor molecules maintain infectious conformation and restrict strain properties in purified prionsNathan R Deleault, Daniel J Walsh, Justin R Piro, et al.
Frontiers in Pharmacology|September 12, 2019
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and DevelopmentKnut Biber, Anindya Bhattacharya, Brian M Campbell, et al.
Cell Reports|July 21, 2012
A dysregulated endocannabinoid-eicosanoid network supports pathogenesis in a mouse model of Alzheimer's diseaseJustin R Piro, Daniel I Benjamin, James M Duerr, et al.
Pageof 2